ArticleScientific reports2025
Machine learning-based mortality risk prediction model for elderly diabetic patients with non-ST-segment elevation myocardial infarction using MIMIC-IV database.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incremental prognostic value of pan-immune-inflammation value in conservatively treated acute myocardial infarction: derivation and MIMIC-IV validation.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Non-ST-elevation myocardial infarction (NSTEMI) in elderly diabetic patients presents unique challenges in risk assessment and prognosis prediction. This study aimed to develop and validate a machine learning-based mortality risk prediction model for this specific population using the MIMIC-IV database. We conducted a retrospective cohort study including 5,272 NSTEMI patients aged ≥ 55 years with diabetes from the MIMIC-IV database. Multiple machine learning models were developed using clinical data collected within 24 h of admission. The primary outcome was 28-day all-cause mortality. Model performance was evaluated using ROC curves, calibration plots, and decision curve analysis. SHAP analysis was employed to interpret model predictions. The XGBoost model demonstrated superior performance (AUC = 0.86) compared to other algorithms and traditional scoring systems. SHAP analysis identified PaO2, Charlson Comorbidity Index, and APSIII score as the top three prognostic factors. Lactate levels showed the broadest influence range (SHAP values - 0.5 to 1.5), while platelet count exhibited distinct bidirectional effects on prognosis. Decision curve analysis confirmed the model's superior clinical utility across all risk threshold intervals. Our machine learning-based prediction model achieved robust performance in predicting 28-day mortality risk for elderly diabetic NSTEMI patients. The model's interpretability analysis revealed complex nonlinear relationships between clinical variables and outcomes, providing valuable insights for risk assessment and clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.